Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Toxicol Sci. 2020 Dec 1;178(2):281–301. doi: 10.1093/toxsci/kfaa147

Figure 6.

Figure 6.

AIME-coupled ERTA metabolism negative test set screening. The ΔAUC and confidence interval derived from ToxBoot uncertainty quantification analysis are plotted with mean ± quantile of 3. Significance of metabolic effects is noted for bioinactivation (blue), no metabolic effect (black), and bioactivation (red) (A). ToxCast pipeline (TCPL) curve fits for metabolism negative (control; blue) and metabolism positive (metabolism; red) assay modes. Vertical lines represent the potency (AC50) for respective assay modes. Horizontal line is the mean response for test guideline E2 controls (grey solid line). Plots are shown for chemicals where significant metabolism-dependent effects were observed. Data points are normalized responses plotted for all experimental replicates (n=3) (B).